Carregant...
Pseudotumor of the Larynx: A Previously Unreported Side Effect of Apremilast
Apremilast (Otezla®) is a relatively novel orally administered non-biologic disease-modifying anti-rheumatic drug (DMARD) extensively used in the management of psoriasis and psoriasis arthritis, lately approved for treating oral ulcerations in Behçets disease. Its advantageous side effect profile to...
Guardat en:
| Publicat a: | Case Rep Dermatol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
S. Karger AG
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7841725/ https://ncbi.nlm.nih.gov/pubmed/33568982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000511697 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|